The inhibition of NRF2 expression resulted in a reduction of GSTA4 expression and GSH-4HNE formation and increased sensitivity to 4HNE-mediated antiproliferation and apoptosis in prostate cancer cells [61]. Here, NFE2L2 is linked to prostate cancer.